This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: EvidenceVariable 236956
version: 66; Last updated: 2025-03-20 18:40:09+0000
RelatesTo
- type: part-of
- targetReference: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)
url: EvidenceVariable OutcomeDefinition: Cardiovascular mortality
identifier: FEvIR Object Identifier/https://fevir.net/FOI/236956, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313957, outcomeId/313957, picoId/85798, sectionId/73215, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.62
version: 1.0.0-ballot2
name: Cardiovascular_mortality313957
title: OutcomeDefinition: Cardiovascular mortality
shortTitle: Cardiovascular mortality
status: Active
date: 2025-03-28 17:11:38+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
Cardiovascular mortality
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
author: Computable Publishing®: MAGIC-to-FEvIR Converter:
handling: dichotomous variable